Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0DU5S
|
||||
| Former ID |
DNC004292
|
||||
| Drug Name |
Quinapril analogue
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [551295] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C52H79Cl2N5O2P+
|
||||
| Canonical SMILES |
CCCC[P+](CCCC)(CCCC)CC1=CC=C(C=C1)NC(=O)C2CC3=CC=CC=C3C<br />N2C(=O)C(CCC4=CC=CC=C4)NC(=NC5CCCCC5)NC6CCCCC6.Cl.Cl
|
||||
| InChI |
1S/C52H76N5O2P.2ClH/c1-4-7-35-60(36-8-5-2,37-9-6-3)40-42-29-32-47(33-30-42)53-50(58)49-38-43-23-19-20-24-44(43)39-57(49)51(59)48(34-31-41-21-13-10-14-22-41)56-52(54-45-25-15-11-16-26-45)55-46-27-17-12-18-28-46;;/h10,13-14,19-24,29-30,32-33,45-46,48-49H,4-9,11-12,15-18,25-28,31,34-40H2,1-3H3,(H2-,53,54,55,56,58);2*1H/p+1/t48-,49?;;/m0../s1
|
||||
| InChIKey |
PDLXBENIAHPVSH-FMRLQMMWSA-O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | B2 bradykinin receptor | Target Info | Inhibitor | [551295] | |
| KEGG Pathway | Calcium signaling pathway | ||||
| cGMP-PKG signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Complement and coagulation cascades | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| Regulation of actin cytoskeleton | |||||
| Endocrine and other factor-regulated calcium reabsorption | |||||
| Chagas disease (American trypanosomiasis) | |||||
| Pathways in cancer | |||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | Direct p53 effectors | ||||
| Validated transcriptional targets of deltaNp63 isoforms | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.